Trivitron Healthcare in collaboration with Diagon-Vanguard Diagnostics launches Diagon’s Coagulation range in India

New Delhi: Trivitron Healthcare has announced the launch of a new line of Coagulation Analyzer products manufactured by Diagon Limited. Trivitron in partnership with Diagon-Vanguard Diagnostics India has announced the introduction of these products for the Indian diagnostics market following the signing of a collaboration agreement between the companies.

As per the company, this launch augurs well for the medical fraternity as it enhances the efficacies in clinical decision-making and broadens patient management. The new products include the COAG Line automated, semi-automated and POC systems manufactured by Diagon Hungary for reducing bleeding risk in extensive surgeries, checking the efficacy of haemostatic therapies and anti-coagulant drugs.

Commenting on the launch Mr. Rajesh Patel, Chief Executive Officer (IVD Business), Trivitron Healthcare said “Trivitron has prided itself in being the leader in innovation in the clinical and medical technology space. With this launch of the product line from Diagon we are looking to broaden the scope and scale of efficacies in patient and clinical management. This range of products will complement Trivitron’s focus on supporting patient management by offering precision in clinical diagnostic fields, such as cardiology, infectious diseases, pathology, biochemistry, as well as inflammatory and autoimmune diseases”.

Commenting on this occasion, Ms. Chandra Ganjoo, Group CPO & Executive Director, Trivitron Healthcare said, “We are expanding and combining our organisational expertise to address the requirements of the medical community by introducing new solutions in the clinical and patient management space.  We are proud to announce the enhancement of our IVD range of clinical use by enabling additional products and devices testing menu to our portfolio.”

Commenting on the cooperation agreement Dr. Marco van der Looij, Director of Global Business Development, Diagon Ltd Hungary & Director, Diagon-Vanguard Diagnostics India added, “We are proud to be associated with Trivitron Healthcare that has over 20 years of IVD and medical device manufacturing and selling experience in India. Together with Diagon-Vanguard-Diagnostics India, we will take our presence in the Indian market to a next level by promoting the Diagon COAG haemostasis systems line providing scalable and automated solutions for hospitals and reference laboratories. We are excited we can now offer our next generation haemostasis solutions to all laboratory sectors in India serving needs from POC testing to high-throughput requirements including critical D-Dimer test for COVID-19.”

Commenting on the launch and cooperation agreement Ms. Veena Kohli, Managing Director Diagon Vanguard Diagnostics (P) Limited India said, “We are looking forward to jointly serving the Indian market by offering the best solutions in Coagulation, customized to meet the needs of all types of testing set-ups.”